Cresco Labs (CRLBF) Filings

6-K

Current report (foreign)

27 Sep 24

6-K

Cresco Labs Announces Dennis Olis to Retire as Chief Financial Officer

12 Sep 24

S-8

Registration of securities for employees

9 Aug 24

6-K

Unaudited Condensed Interim Consolidated Financial Statements

8 Aug 24

6-K

Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders

11 Jul 24

6-K

Notice of Annual General and Special Meeting and Management Information Circular

10 Jun 24

6-K

Unaudited Condensed Interim Consolidated Financial Statements

15 May 24

40-F

2023 FY

Annual report (Canada)

15 Mar 24

6-K

Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements

13 Mar 24

6-K

Current report (foreign)

6 Feb 24

6-K

Unaudited Condensed Interim Consolidated Financial Statements

15 Nov 23

F-X

Appointment of agent for service of process by issuers registering securities

17 Aug 23

F-10

Registration of securities (Canada)

17 Aug 23

6-K

Current report (foreign)

16 Aug 23

6-K

Cresco Labs and Columbia Care Mutually Agree to Terminate Merger

31 Jul 23

6-K

Cresco Labs and Columbia Care Provide Update on Transaction

30 Jun 23

6-K

Unaudited Condensed Interim Consolidated Financial Statements

25 May 23

40-F

2022 FY

Annual report (Canada)

22 Mar 23

6-K

Cresco Labs Announces Fourth Quarter & Full Year 2022 Results

16 Mar 23

6-K

Current report (foreign)

17 Nov 22

6-K

Cresco Labs Announces Board Director Sidney Dillard’s Resignation

25 Oct 22

6-K

Cresco Labs Announces Second Quarter 2022 Results

23 Aug 22

6-K

Amended and Restated Investment Agreement

21 Jun 22

6-K

Notice of Availability of Proxy Materials

15 Jun 22

6-K

Cresco Labs Announces First Quarter 2022 Results

19 May 22

40-F

2021 FY

Annual report (Canada)

5 Apr 22

6-K

Material Change Report

4 Apr 22

6-K

Cresco Labs Announces Fourth Quarter & Full Year 2021 Results with Record Revenue, Adjusted

1 Apr 22

D

$62.13M in equity, sold $62.13M, 76 investors

21 Dec 21

6-K

Current report (foreign)

22 Nov 21

6-K

Cresco Labs Announces Third Quarter 2021 Financial Results

15 Nov 21

6-K

Cresco Labs to Acquire Three High-performing Pennsylvania Dispensaries

27 Sep 21

6-K

Cresco Labs Closes Acquisition of Cultivate, Strengthens Position In Forward Looking Statements

8 Sep 21

6-K

Senior Secured Term Loan Agreement

27 Aug 21

6-K

Notice of Annual and Special Meeting of Shareholders

11 Jun 21

6-K

Current report (foreign)

1 Jun 21

6-K

Cresco Labs Announces First Quarter 2021 Financial Results Under U.S. GAAP

28 May 21

6-K

Cresco Labs Announces the Appointment of Sidney Dillard to Its Board of Directors

21 May 21

6-K

Current report (foreign)

3 May 21

40-F/A

2020 FY

Annual report (Canada) (amended)

29 Apr 21

SC 13D

Cresco Labs / Cresco Labs ownership change

16 Feb 24

SC 13D

Cresco Labs / Cresco Labs ownership change

16 Feb 24

SC 13G

Cresco Labs / Cresco Labs ownership change

16 Feb 24

SC 13G

Cresco Labs / Cresco Labs ownership change

14 Feb 24

SC 13G

Cresco Labs / Cresco Labs ownership change

14 Feb 24

SC 13G

Cresco Labs / Cresco Labs ownership change

14 Feb 24

SC 13G

NOMURA HOLDINGS INC

14 Feb 24

SC 13G/A

Cowen Financial Products LLC

2 Feb 24

SC 13G/A

Cowen Financial Products LLC

23 Jan 23

SC 13G

Sampson Robert M

14 Feb 22

SC 13G

Bachtell Charles Ian

14 Feb 22

SC 13G

Sergi Dominic

14 Feb 22

SC 13G/A

Cowen Financial Products LLC

20 Jan 22

SC 13G

Cowen Financial Products LLC

31 Mar 21